Learn more about our team

About Us

ViveBio Scientific is a biotechnology company that was founded on the premise of providing a better and more cost-effective method of transporting HIV-infected human serum from remote areas of the world to the United States for proper testing. Through the development and implementation of the first ViveST® transport tube, ViveBio Scientific provided researchers a tool to ship HIV-infected samples around the world for critical viral load and resistance testing in a safe and inexpensive format. Since that start, ViveBio Scientific has not stopped trying to innovate and advance the sample collection space.
 

Now, since our first breakthrough, our original mission has grown and evolved into an effort to bring products to the market that can help provide better healthcare access to all around the world who need it. Today, the ViveST® transport tube is still the only device on the market to provide a high volume (1.5mL) dried sample transport matrix for ambient sample transport and storage. In addition to this, ViveBio Scientific has launched the first device designed to collect and separate the cellular components from the liquid component of whole blood; generating purified plasma which is then dried and stabilized. Collecting blood from a finger stick, The PRISM® accomplishes this thus allowing for a wider variety of downstream testing that was previously negatively impacted by today’s technologies for sample collection. Of particular note and importance are markers for routine nutritional testing. Since the PRISM® requires no infrastructure for collecting the specimen and has no know downstream testing constraints, it has the potential to bring basic healthcare monitoring to areas that may not have had access to such in the past.
 

Moving forward, ViveBio Scientific’s goal is to work with others in the effort to bring better and basic healthcare access to resource poor areas of the world. We believe that our technology in the hands or the right people with existing infrastructure and reach could one day make a positive difference in world health, including Biomarkers for Alzheimers and other diseases.